| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.23 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |